These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

845 related articles for article (PubMed ID: 9746770)

  • 21. Del (9q) AML: clinical and cytological characteristics and prognostic implications.
    Peniket A; Wainscoat J; Side L; Daly S; Kusec R; Buck G; Wheatley K; Walker H; Chatters S; Harrison C; Boultwood J; Goldstone A; Burnett A
    Br J Haematol; 2005 Apr; 129(2):210-20. PubMed ID: 15813849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.
    Lugthart S; Gröschel S; Beverloo HB; Kayser S; Valk PJ; van Zelderen-Bhola SL; Jan Ossenkoppele G; Vellenga E; van den Berg-de Ruiter E; Schanz U; Verhoef G; Vandenberghe P; Ferrant A; Köhne CH; Pfreundschuh M; Horst HA; Koller E; von Lilienfeld-Toal M; Bentz M; Ganser A; Schlegelberger B; Jotterand M; Krauter J; Pabst T; Theobald M; Schlenk RF; Delwel R; Döhner K; Löwenberg B; Döhner H
    J Clin Oncol; 2010 Aug; 28(24):3890-8. PubMed ID: 20660833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytogenetic findings and clinical outcomes of adult acute myeloid leukaemia patients.
    Sahin FI; Kizilkilic E; Bulakbasi T; Yilmaz Z; Boga C; Ozalp O; Karakus S; Ozdogu H
    Clin Exp Med; 2007 Sep; 7(3):102-7. PubMed ID: 17972052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of specific cytogenetic aberrations with mdr1 gene expression in adult myeloid leukemia and its implication in treatment outcome.
    Schaich M; Harbich-Brutscher E; Pascheberg U; Mohr B; Soucek S; Ehninger G; Illmer T
    Haematologica; 2002 May; 87(5):455-64. PubMed ID: 12010657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12.
    Harrison CJ; Hills RK; Moorman AV; Grimwade DJ; Hann I; Webb DK; Wheatley K; de Graaf SS; van den Berg E; Burnett AK; Gibson BE
    J Clin Oncol; 2010 Jun; 28(16):2674-81. PubMed ID: 20439644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics and prognostic factors of acute myeloid leukemia with t (8; 21) (q22; q22).
    Lai YY; Qiu JY; Jiang B; Lu XJ; Huang XJ; Zhang Y; Liu YR; Shi HL; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):733-40. PubMed ID: 16277833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytogenetic abnormalities in de novo acute myeloid leukemia in adults: relation to morphology, age, sex and ethnicity - a single center study from Singapore.
    Enjeti AK; Tien SL; Sivaswaren CR
    Hematol J; 2004; 5(5):419-25. PubMed ID: 15448668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of cytogenetic and molecular cytogenetic detection of chromosome abnormalities in 240 consecutive adult patients with acute myeloid leukemia.
    Fröhling S; Skelin S; Liebisch C; Scholl C; Schlenk RF; Döhner H; Döhner K;
    J Clin Oncol; 2002 May; 20(10):2480-5. PubMed ID: 12011125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia?
    Larson RA
    Best Pract Res Clin Haematol; 2007 Mar; 20(1):29-37. PubMed ID: 17336252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML.
    Nishii K; Usui E; Katayama N; Lorenzo F; Nakase K; Kobayashi T; Miwa H; Mizutani M; Tanaka I; Nasu K; Dohy H; Kyo T; Taniwaki M; Ueda T; Kita K; Shiku H
    Leukemia; 2003 Apr; 17(4):731-7. PubMed ID: 12682630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A white blood cell index as the main prognostic factor in t(8;21) acute myeloid leukemia (AML): a survey of 161 cases from the French AML Intergroup.
    Nguyen S; Leblanc T; Fenaux P; Witz F; Blaise D; Pigneux A; Thomas X; Rigal-Huguet F; Lioure B; Auvrignon A; Fière D; Reiffers J; Castaigne S; Leverger G; Harousseau JL; Socié G; Dombret H
    Blood; 2002 May; 99(10):3517-23. PubMed ID: 11986202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases.
    Morel P; Hebbar M; Lai JL; Duhamel A; Preudhomme C; Wattel E; Bauters F; Fenaux P
    Leukemia; 1993 Sep; 7(9):1315-23. PubMed ID: 8371581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cytogenetic risk categories in acute myeloid leukemia: a comparison between MRC (Medical Research Council) and SWOG (Southwest Oncology Group) models)].
    Martín Ramos ML; López Pastor M; de la Serna Torroba J; Ayala R; García Alonso L; Barreiro Miranda E
    Med Clin (Barc); 2003 Jun; 121(4):121-5. PubMed ID: 12867014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Classical and molecular cytogenetic abnormalities and outcome of childhood acute myeloid leukaemia: report from a referral centre in Israel.
    Stark B; Jeison M; Gabay LG; Mardoukh J; Luria D; Bar-Am I; Avrahami G; Kapeliushnik Y; Sthoeger D; Herzel G; Steinberg DM; Cohen IJ; Goshen Y; Stein J; Zaizov R; Yaniv I
    Br J Haematol; 2004 Aug; 126(3):320-37. PubMed ID: 15257704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working Parties.
    Wheatley K; Burnett AK; Goldstone AH; Gray RG; Hann IM; Harrison CJ; Rees JK; Stevens RF; Walker H
    Br J Haematol; 1999 Oct; 107(1):69-79. PubMed ID: 10520026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Ferrant A; Labopin M; Frassoni F; Prentice HG; Cahn JY; Blaise D; Reiffers J; Visani G; Sanz MA; Boogaerts MA; Löwenberg B; Gorin NC
    Blood; 1997 Oct; 90(8):2931-8. PubMed ID: 9376573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognosis of acute myeloid leukemia patients up to 60 years of age exhibiting trisomy 8 within a non-complex karyotype: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup.
    Schaich M; Schlenk RF; Al-Ali HK; Döhner H; Ganser A; Heil G; Illmer T; Krahl R; Krauter J; Sauerland C; Büchner T; Ehninger G
    Haematologica; 2007 Jun; 92(6):763-70. PubMed ID: 17550848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.
    von Neuhoff C; Reinhardt D; Sander A; Zimmermann M; Bradtke J; Betts DR; Zemanova Z; Stary J; Bourquin JP; Haas OA; Dworzak MN; Creutzig U
    J Clin Oncol; 2010 Jun; 28(16):2682-9. PubMed ID: 20439630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytogenetics and age are major determinants of outcome in intensively treated acute myeloid leukemia patients older than 60 years: results from AMLSG trial AML HD98-B.
    Fröhling S; Schlenk RF; Kayser S; Morhardt M; Benner A; Döhner K; Döhner H;
    Blood; 2006 Nov; 108(10):3280-8. PubMed ID: 16840728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parameters for predicting allogeneic PBSCT outcome of acute myeloid leukemia: cytogenetics at presentation versus disease status at transplantation.
    Kim DH; Sohn SK; Kim JG; Lee NY; Sung WJ; Baek JH; Suh JS; Lee KS; Lee KB
    Ann Hematol; 2005 Jan; 84(1):25-32. PubMed ID: 15349754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.